Vaccinex, Inc. (VCNX) DCF Valuation

Vaccinex, Inc. (VCNX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Vaccinex, Inc. (VCNX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore Vaccinex, Inc.'s (VCNX) financial prospects using our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and expenses to calculate Vaccinex, Inc.'s (VCNX) intrinsic value and enhance your investment approach.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .5 .1 .9 .1 .6 .6 .6 .7 .7 .7
Revenue Growth, % 0 -90.44 1700 -88.89 470 5.17 5.17 5.17 5.17 5.17
EBITDA -31.6 -28.1 -21.4 -19.6 -19.7 -.6 -.6 -.7 -.7 -.7
EBITDA, % -6044.74 -56110 -2378 -19606 -3464.56 -100 -100 -100 -100 -100
Depreciation .2 .3 .2 .2 .1 .3 .4 .4 .4 .4
Depreciation, % 47.61 614 18.78 207 20.88 57.45 57.45 57.45 57.45 57.45
EBIT -31.9 -28.4 -21.6 -19.8 -19.9 -.6 -.6 -.7 -.7 -.7
EBIT, % -6092.35 -56724 -2396.78 -19813 -3485.44 -100 -100 -100 -100 -100
Total Cash 2.8 10.6 8.6 6.4 1.5 .6 .6 .7 .7 .7
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .9 .2 .0 .2 1.0
Account Receivables, % 171.7 314 0 175 168.6
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0.000191204589 0.002 0 0.001 0 0.000638240918 0.000638240918 0.000638240918 0.000638240918 0.000638240918
Accounts Payable 3.2 3.2 1.1 1.5 2.0 .6 .6 .7 .7 .7
Accounts Payable, % 613.38 6338 117.89 1518 357.72 100 100 100 100 100
Capital Expenditure -.1 -.3 .0 -.1 -.1 -.3 -.3 -.3 -.3 -.3
Capital Expenditure, % -14.91 -580 -3.56 -99 -11.75 -45.84 -45.84 -45.84 -45.84 -45.84
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -32.0 -28.8 -22.4 -19.7 -19.9 -.6 -.6 -.7 -.7 -.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -29.5 -28.1 -24.2 -19.3 -20.1 -1.5 -.6 -.6 -.6 -.6
WACC, % 7.55 7.55 7.55 7.55 7.55 7.55 7.55 7.55 7.55 7.55
PV UFCF
SUM PV UFCF -3.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1
Terminal Value -12
Present Terminal Value -8
Enterprise Value -11
Net Debt -1
Equity Value -10
Diluted Shares Outstanding, MM 0
Equity Value Per Share -21.80

What You Will Get

  • Real VCNX Financial Data: Pre-filled with Vaccinex’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Vaccinex’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • 🔍 Real-Life VCNX Financials: Pre-filled historical and projected data for Vaccinex, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Vaccinex’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Vaccinex’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Obtain the pre-formatted Excel file featuring Vaccinex, Inc.'s (VCNX) financial data.
  • Customize: Modify projections such as revenue growth, EBITDA %, and WACC to fit your analysis.
  • Update Automatically: Watch as intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and evaluate results instantly.
  • Make Decisions: Leverage the valuation insights to inform your investment approach.

Why Choose This Calculator for Vaccinex, Inc. (VCNX)?

  • Accurate Data: Up-to-date Vaccinex financials provide trustworthy valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you from starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Simple layout and clear instructions make it accessible for all users.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and trustworthy valuation models for analyzing investments in Vaccinex, Inc. (VCNX).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in Vaccinex, Inc. (VCNX).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling related to biotech.
  • Biotech Enthusiasts: Gain insights into how biotech firms like Vaccinex, Inc. (VCNX) are valued in the financial market.

What the Template Contains

  • Preloaded VCNX Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

Es wurden keine passenden Produkte gefunden.